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Abstract
Background: The use of drugs to attenuate the haemodynamic response to laryngoscopy and endotracheal intubation is the standard of care during elective surgery. Current evidence is conflicting concerning the best agent and optimal dose for this purpose.
In the majority of cases, fentanyl is widely utilized to attenuate haemodynamic responses. Ketamine, an established available drug,
has been scarcely studied in this regard at low doses and against varying doses of other common agents.
Objective: To compare the overall occurrence of hypertension and tachycardia immediately pre-intubation (post-induction) until
10 minutes post intubation between the study group receiving fentanyl at 1.0 µg/kg and the other receiving ketamine at 0.5 mg/kg,
to compare the occurrence of post-induction hypotension and the occurrence of neuropsychiatric phenomena during emergence
between the two groups.
Methods: One hundred and eight ASA I and II patients aged 18-65 years scheduled for elective surgery under general anaesthesia
were randomized into two groups: Control group: received fentanyl 1.0 µg/kg intravenously. Intervention group: received ketamine
0.5 mg/kg intravenously. General anaesthesia was standardized in both groups. The patients and physicians administering anaesthesia were blinded to the study. Haemodynamic responses were evaluated by determining heart rate and blood pressure immediately
before laryngoscopy and at 2.5, 5, 7.5 and 10 minutes. Neuropsychiatric phenomena were assessed upon recovery from anaesthesia.
Results: One hundred and eight ASA I and II patients scheduled to undergo elective surgery were included in this study, 54 participants (50%) in the fentanyl arm and 54 (50%) in the ketamine arm. Baseline demographic characteristics were similar between the
groups. There were more hypertensive episodes in the ketamine arm (11%) compared to the fentanyl arm (1.85%), but not achieving statistical significance: Fisher’s exact test, p=0.06. There was no significant difference in the number of episodes of tachycardia
between the Ketamine group 7/54 (13%) and the fentanyl group, 6/54 (11%); x2=0.05, p=0.82. Hypotensive episodes were more
common in those who received Fentanyl, 41/54 (76%), compared to ketamine recipients, 21/54 (39%), X2=16.9, p<0.001. The
use of Ketamine was associated with less episodes of hypotension, adjusted odds ratio = 0.18 (95% confidence interval 0.07, 0.45).
Conclusion: We conclude, based upon findings in this study group, that there is no difference in the occurrence of hypertension
with the use ketamine at 0.5 mg/kg in combination with Propofol at 2.0 mg/kg. In this regard, ketamine provides a viable alternative to fentanyl at 1.0 µg/kg for attenuating the pressor response to laryngoscopy and endotracheal intubation. Additionally, our
results suggest that ketamine may protect against post-induction (pre-laryngoscopy) hypotension.
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Introduction
General anaesthesia with direct laryngoscopy and endotracheal intubation (LTI) is frequently used in surgical patients. Even with a trend towards increased use of
regional and local anaesthetic techniques (with or without sedation), general anaesthesia with LTI remains the
choice for several forms of surgery e.g. maxillofacial sur-
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gery, cardiothoracic surgery, laparoscopic abdominal surgery and procedures requiring rapid sequence induction1.
Laryngoscopy and endotracheal intubation is one of the
most haemodynamically stimulating points during the
course of the general anaesthesia. The mechanisms proposed include a somato-visceral reflex, stimulation of proprioceptors at the base of the tongue with catecholamine
release and vagal inhibition of the heart2. This provokes
a haemodynamic response characterized by an increase in
heart rate (up to 83%) and blood pressure (up to 80%)3.
These haemodynamic changes typically start within 5 seconds of laryngoscopy and peak 1 min after initiation of
intubation and persist for 5-10 minutes4-6. This may lead
to myocardial ischemia, ventricular arrhythmia, left ventricular failure and cerebral haemorrhage7.

Fentanyl is a synthetic opioid analgesic with a potency
of approximately 75 -125 times that of morphine. It is
the most commonly used agent in Aga Khan University
Hospital, Nairobi, for attenuating this pressor response.

Ketamine, a phencyclidine derivative, is an N-Methyl D-Aspartate receptor antagonist that also acts at numerous other sites. It inhibits opioid mu receptors while
stimulating delta and kappa receptors. Ketamine is in
wide use as an anaesthetic, sedative and analgesic agent.
Intravenous induction doses for anaesthesia range from
1-2mg/kg (with an intramuscular induction dose of
5-10mg/kg.) Ketamine is widely available yet has scarcely
been soundly studied as an agent for the attenuation of
haemodynamic response to LTI20. Indeed, it is known to
cause hypertension and tachycardia at anaesthetic doses.
Various factors affect the magnitude of this response. A This cardio-stimulatory effect is however minimal to nil
variety of anaesthetic techniques and drugs have been at sub-anaesthetic/analgesic doses15.
studied and are available to control the hemodynamic response to laryngoscopy and intubation7. Induction This study was designed to compare the overall occurdrugs may attenuate adverse hemodynamic responses to rence of hypertension in response to laryngoscopy and
laryngoscopy and endotracheal intubation7. Well studied endotracheal intubation between low-dose ketamine veragents/modalities include opioids, local anaesthetics, beta sus fentanyl in patients undergoing general anaesthesia.
blockers, calcium channel blockers, benzodiazepines, bar- Considering the enormous effect of anaesthetic drugs on
biturates, alpha adrenergic antagonists, vasodilators, alpha the patients’ haemodynamics during and after intubation,
2 agonists, angiotensin converting enzyme inhibitors, lor- this study intends to explore a possible alternative reginoxicam, inhalational anaesthetics, pregabalin and nerve men to reduce this morbidity. Our study question is: does
blocks3,8-14. In a 2013 Cochrane review of 72 RCTs16, low-dose ketamine result in lower occurrence of post laall studies reporting arrhythmias were analysed and 49 ryngoscopy and intubation tachycardia and hypertension
trials enrolling lower risk patients revealed a significant compared to fentanyl?
difference observed between the placebo and treatment
groups (OR 0.20, 95% CI 0.14 to 0.28, P < 0.00001, I2 We hypothesized that there is no difference in the occur= 44%). This review suggests that even low risk (ASA rence of post-laryngoscopy and intubation hypertension
I/II) patients are susceptible to cardiac arrhythmia and and tachycardia in patients who receive pre-laryngoscopy
ECG evidence of myocardial ischaemia as a consequence and intubation low dose ketamine versus fentanyl. Our
of haemodynamic changes related to tracheal intubation. primary objective was to compare the effect of low-dose
Of these low risk patients, 13% had arrhythmias and 1.4 ketamine versus fentanyl on the occurrence of hyper% had myocardial ischaemia when a placebo was given tension in patients undergoing general anaesthesia. Our
prior to laryngoscopy and intubation. Pre-induction use secondary objectives were to compare the occurrence of
of pharmacological agents reduced this risk to 4.5% for tachycardia between the two study groups, compare the
occurrence of pre-laryngoscopy and intubation hypotenarrhythmias and nil for myocardial ischaemia16.
These drugs and their various combinations have been sion between the two study groups and to compare the
tried in the past and studies have highlighted their use in occurrence of neuropsychiatric phenomena upon recovvarying doses for the suppression of this stress response ery from anaesthesia.
but with significant occurrence of adverse effects, espeMethods
cially with use of higher doses of opioids9.
The study was performed following approval from the re-
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search scientific and ethical committees of the Aga Khan
University, East Africa. This was a prospective, double
blinded, and randomized controlled trial. Patients were
recruited from the outpatient pre-anaesthesia clinics as
well as the day care and in-patient wards. The target population included patients admitted for elective and urgent
surgery under general anaesthesia with laryngoscopy and
endotracheal intubation at the Aga Khan University Hospital, Nairobi. The sample population included American Society of Anesthesiologists (ASA) physical status
(PS) I and II patients going to theatre for elective surgery
between November 2015 and April 2016.
All ASA I and II patients 18-65 years scheduled for elective surgery aged between 18 and 65 years were included
in the study. Reasons for exclusion from the study were:
1. History of allergy or contraindications to any of the
study drugs.
2. Patients scheduled for emergency surgery.
3. Age below 18 years and above 65 years.
4. Hypertension – a known/previously diagnosed hypertensive as per the American Heart Association guidelines.
5. Pregnancy.
6. Dementia/psychiatric illness.
7. Known ischaemic heart disease.
8. Known raised intracranial pressure or intracranial pathology where a rise in intracranial pressure would pose
a risk or patients scheduled for neurosurgical procedures.
9. History, indicator (Mallampati score) of or proven difficult ventilation/laryngoscopy/intubation.
10. Intubation time greater than 30 seconds/Repeat attempts at intubation.
11. Patients who did not agree to the clinical trial.
Previous studies show incidence of tachycardia and hypertension of 55% and 40% respectively with fentanyl
(versus 85% and 80% respectively with controls).3 This
represents a 30% decrease in tachycardia and hypertension than control. This study sought to identify a further
30% decrease in these haemodynamic parameters with
use of low dose ketamine (compared to Fentanyl). Using
this information and assuming 5% significance level and
power of 80%, a sample size of 80 patients was found
sufficient to demonstrate a 30% difference in the incidence of hypertension and of tachycardia between pa-
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tients undergoing general anaesthesia with LTI given low
dose Ketamine versus Fentanyl. The study was powered
at 80%. Type 1 error was set at 0.05. Accounting for a
10% drop-out gave us a total sample size of 88 with 44
patients in each study arm.
Study participants were recruited after screening to determine eligibility and obtaining informed consent for the
study. Participants were screened during the pre-operative
anaesthesia assessment session in the anaesthesia clinic,
in-patient wards and day care unit. Consecutive sampling
was employed such that every available subject eligible for
selection was recruited. All potential participants received
a verbal and written explanation on the purpose and procedure of the study from the principal investigator and
written informed consent sought. The patients who gave
written informed consent were enrolled into the study
and then randomized.
The participants were randomly allocated to either arm
using simple randomization. A random allocation sequence was generated by a statistician using a computer
algorithm and consenting participants were allocated to
either arm based on the random allocation sequence. The
principal investigator was not engaged in the generation
of the random allocation sequence. The statistician had
envelopes that were serialized to correspond to the aforementioned random allocation sequence. Once a patient
gave informed consent, the clinician screening the patient
attached the envelope to the anaesthesia chart/data collection tool/consent form. Once the participant arrived
in the pre-operative receiving area of the main theatres, a
research assistant not involved in any other aspect of the
study received these envelopes containing the allocation
number that he used to know what drug to give according
to the allocation chart available to him only. He then proceeded to prepare the appropriate drug up to a volume
of 10mL. Identical 10 mL syringes labelled “Study Drug”
were used. The drug was then presented to the anaesthesiologist in the operating theatre. Both Fentanyl and Ketamine are colourless/clear liquids and so the presentation
was identical. In this way, the participant, principal investigator and the anaesthesiologist in the operating theatre
remained blinded to the group allocation. Flow diagram
of patient distribution is shown in figure 1.
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Screening (Anesthesia clinic, Daycare
unit, In-patient wards)

Patient assessed for eligibility by principal investigator
and appropriately trained research assistant. ELIGIBLE?

Excluded (continued to
receive appropriate
anaesthesia service and
care)

N0

Yes
117
Informed consent obtained by principal investigator and
appropriately trained research assistant?

No 9

Yes
108

Patient randomized
108

Fentanyl group

Ketamine group

54

54

Analysis 108

Figure 1. Flow diagram of patient distribution

On arrival in the operating theatre, standard monitoring
was applied with automated non-invasive blood pressure
measurement, electrocardiography and pulse oximetry,
with the objective of obtaining the baseline cardiovascular parameters. Baseline blood pressure was obtained by
taking three readings and calculating an average of the
three readings.
Intravenous access was obtained and 10mL/kg of Normal Saline or Ringer’s Lactate administered over the induction period.
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At least 3 minutes of pre-oxygenation was performed.
Fentanyl group participants received 1.0 µg/kg fentanyl and 2.0 mg/kg propofol as intravenous bolus doses
5 minutes prior to laryngoscopy. Ketamine group participants received 0.5 mg/kg ketamine and 2.0 mg/kg
propofol as intravenous bolus doses 5 minutes prior to
laryngoscopy. 0.2 mg/kg Cisatracurium was administered
as an intravenous bolus dose within 1 minute of administering Fentanyl/Ketamine and Propofol.
Ventilation with 1% Isoflurane in oxygen via a Mapleson
A circuit was initiated followed by laryngoscopy with an
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appropriately sized Macintosh laryngoscope and endotracheal intubation with an appropriately sized cuffed endotracheal tube. This was to commence 3 minutes after the
administration of muscle relaxant.
Haemodynamic and other monitoring parameters were
observed continuously and recorded at 1 minute post induction (on administration of study drug and Propofol)
and then at intervals of 2.5 minutes each for the first 10
minutes.
Upon reversal of anaesthesia (recovery in the post-anaesthesia care unit – PACU) the patient was observed for any
neuropsychiatric manifestations such as hallucinations
and confusion not attributed to the usual post-general
anaesthesia emergence. This information was recorded in
the data collection tool.
Any episode of hypertension persisting more than 20
minutes was to be managed by deepening the plane of
anaesthesia with Isoflurane or if refractory, with 10 mg
boluses of intravenous labetalol titrated to effect. Any
incidence of persistent hypotension was to be managed
either 3 mg intravenous boluses of Ephedrine or 50 mcg
intravenous boluses of Phenylephrine. Neuropsychiatric
phenomena were to be identified upon recovery as either
hallucinations or confusion not attributed to the realm of
immediate recovery after general anaesthesia. These were
to be managed with 1 mg intravenous boluses of Midazolam. Pre-emptive use of Midazolam (after the end of
the study) could be administered at the discretion of the
anaesthesiologist. Any complications that occurred were
to be noted by the anaesthesiologist.
Intraoperative data was collected by the anaesthesiologist
administering anaesthesia using the data collection form.
The principal investigator verified all raw data entered
was complete. Data analysis was undertaken using the
SPSS version 15. General baseline demographic characteristics (age, sex, ASA status) between the two groups
were expressed as percentages. Baseline characteristics
between the two groups were summarised as proportions for categorical variables and as means (±standard
deviation) or medians (interquartile ranges) for normally distributed and non-normally distributed continuous
variables respectively.
Characteristics of patients who received ketamine and
fentanyl were compared using chi-squared test or Fisher’s
exact test for proportions as appropriate. Fisher’s exact
test was used when any cell value in the two by two ta2756

ble was ≤ 5. Student t-test was used to compare means
for normally distributed continuous variables between
patients who received Fentanyl and those who received
Ketamine. Non-parametric test, Wilcoxon rank-sum test,
was used to compare medians between the two groups
for non-normally distributed continuous variables.
The primary outcome was increase of SBP of more than
20% from the baseline (considered clinically significant).
Proportions in the ketamine and fentanyl arms with primary outcome were compared using the Fisher’s exact
test. Similar comparison of proportions was used for
secondary outcomes which included the following: the
occurrence of tachycardia (heart rate increase more than
20% from baseline) between the two study groups; occurrence of post-induction, pre-laryngoscopy hypotension (decrease in MAP of more than 20%) between the
two study groups; and incidence of neuropsychiatric phenomena upon recovery from anesthesia. Chi-square test
was used for comparison of proportions where appropriate (when all cell values in the two by two table were > 5).
The association between the drugs (Ketamine or Fentanyl) and hypertension, hypotension and tachycardia was assessed by calculation of odds ratios (and 95% confidence
intervals). Multivariable logistic regression was done, and
odds ratios calculated, to test for independent association
between the drugs and the outcome of interest (hypertension, hypotension and tachycardia). Variables adjusted
for in the multivariable model were age, ASA status and
sex.
Graphical representations showing changes in SBP, MAP,
DBP and heart rates over times between Ketamine and
Fentanyl groups were also done. Time to event analyses
were done and Kaplan Meier survival curves drawn to
compare time to development of hypertension or hypotension between the two groups. Logrank test was used
for statistical comparison of time
Results
One hundred and eight ASA I and II patients scheduled
to undergo elective surgery were included in this study.
There were 54 participants (50%) in the Fentanyl arm
and 54 (50%) in the Ketamine arm. Fifty four percent
(58) were female, 88 (82%) had ASA I status, none had
neuropsychiatric manifestations, median age was 37 years
(interquartile range, 29-46), and the mean body weight
was 68.2(±12.3) kilogram.
African Health Sciences Vol 19 Issue 3, September, 2019

Patients enrolled to Ketamine and Fentanyl groups were randomised to the Ketamine group were generally older
similar in sex, ASA status, weight and had similar blood than those randomised to the Fentanyl arm but this did
pressure at baseline as shown in table 1 below. Patients not achieve statistical significance.
Table 1: Comparison of baseline characteristics between fentanyl and ketamine groups
Fentanyl group

Ketamine group

Baseline patients characteristics

n(%)

n(%)

p value

Female Sex

28(52)

30(56)

0.85

ASA I

44(81)

44(81)

ASA II

10(19)

10(18)

0.93

Mean(±SD)

Mean(±SD)

p value

Age (years)

34.4(9.5)

38.2(10.8)

0.053

Weight (kg)

68.6(11.0)

68.2(12.3)

0.871

Systolic Blood Pressure (mmHg)

124.4(16.6)

121.0(14.3)

0.255

Diastolic Blood Pressure (mmHg)

76.5(9.2)

76.5(9.6)

0.967

Mean Blood Pressure (mmHg)

92.5(11.1)

91.4(10.3)

0.588

Heart Rate (bpm)

76.6(10.5)

75.9(10.6)

0.74

Seven participants developed hypertension (>20% in- of follow up; 6/54 in the Ketamine arm (11.11%) and
crease in baseline) after induction during the duration 1/54 was in the Fentanyl arm (1.85%) as shown in table 2.
Table 2: Proportion of hypertension between fentanyl and ketamine groups
Fentanyl

Ketamine

Total

n(%)

n(%)

n(%)

Hypertension post-baseline Absent

52(51)

49(49)

101

Hypertension post-baseline Present

1(14)

6(86)

7

Total

Fisher’s exact test, p=0.06

There were more hypertensive episodes in the Ketamine
arm compared to the Fentanyl arm, but not achieving statistical significance: Fisher’s exact test, p=0.06.
The cases with hypertension were mainly due to increase
in mean arterial pressure (n=5) and only 1 case each was
seen for hypertension due to increase in systolic or diastolic blood pressures. The patient who developed systol-
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ic hypertension did so at 7.5 minutes but this was normal
at 10 minutes and the one who developed diastolic hypertension did so from 1 minute of follow up but had
normalised by 10 minutes. At 1 minute, two participants
had hypertension diagnosed from increase in mean blood
pressure but these resolved by 7 minutes when 3 others
had hypertension and two persisted until 10 minutes.
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While accounting for confounders, the association of use
of Ketamine with hypertension after adjusting for sex,
age and ASA status produced an adjusted odds ratio =
6.36 (95% confidence interval 0.71, 57.4). This was not
statistically significant.

Mean blood pressures were higher post-baseline in the
Ketamine group compared to the Fentanyl group as summarised in table 3. This study was however not powered
to detect this difference and indeed, this was not deemed
clinically significant given that the overall occurrence of
hypertension was not statistically significantly higher with
the Ketamine than the Fentanyl group.

Table 3: Comparison of blood pressure between fentanyl and ketamine groups
Time

(min)

post-

Ketamine group

Fentanyl group

induction

Mean(±SD

P value

SBP (mmHg)
1min

99.4(8.5)

106.7(11.3)

<0.001

2.5min

96.8(8.2)

107.1(11.3)

<0.001

5min

103.0(8.1)

110.7(8.1)

<0.001

7.5min

98.6(8.8)

113.7(10.2)

<0.001

10min

99.0(5.9)

111.9(7.3)

<0.001

DBP (mmHg)
1min

59.6(7.1)

67.5(8.8)

<0.001

2.5min

59.1(7.0)

67.3(8.9)

<0.001

5min

64.2(7.6)

70.0(7.6)

<0.001

7.5min

62.3(8.3)

72.0(7.6)

<0.001

10min

63.5(8.0)

69.6(7.9)

<0.001

MAP (mmHg)
1min

72.9(6.9)

80.5(9.4)

<0.001

2.5min

71.7(6.8)

80.4(9.6)

<0.001

5min

77.1(7.2)

83.6(7.4)

<0.001

7.5min

74.4(8.0)

85.8(8.3)

<0.001

10min

75.3(6.2)

83.5(6.0)

<0.001

Mean systolic blood pressures were higher in the Ketamine arm compared to the Fentanyl arm over the duration of follow up; Ketamine β-coefficient=7.95(5.96,
9.95), p<0.001. On assessing the absolute differences in
mean values, this was not seen as clinically significant.
The significant outcome measure was the difference from
baseline rather the difference between the groups. Similarly linear regression done comparing mean MAPs (controlling for sex, age and ASA status) showed higher mean
MAP in the Ketamine group compared to the Fentanyl
group during the period of follow up; Ketamine β-coefficient=6.63(5.06, 8.20), p<0.001. Again, on assessing
2758

the absolute differences in mean values, this was not seen
as clinically significant. The significant outcome measure
was the difference from baseline rather the difference between the groups.
Higher mean diastolic blood pressure were seen in the
ketamine arm during the period of follow up, Ketamine
β-coefficient=6.11(4.67, 7.55), p<0.001. Once again, on
assessing the absolute differences in mean values, this was
not seen as clinically significant. The significant outcome
measure was the difference from baseline rather the difference between the groups.
African Health Sciences Vol 19 Issue 3, September, 2019

Even though the hypertensive episodes observed in the
Ketamine group did not reach statistical significance, survival probability against hypertension was analysed and it
shows faster development of hypertension in those treated with Ketamine, Logrank test, p<0.001. Of note is that
in the 10 minute period both the Ketamine and Fentanyl
groups had a less than 15% probability of developing hypertension.

Overall, 62(57%) of participants developed hypotension
(fall >20% post baseline) during follow up. This was
more common in those who received Fentanyl, 41/54
(76%), compared to Ketamine recipients, 21/54 (39%),
X2=16.9, p<0.001. This suggests a trend towards more
post-induction hypotension with Fentanyl use (the study
was not powered to detect this difference). The use of
Fentanyl was associated with more episodes of hypotension, adjusted odds ratio = 5.5 (95% confidence interval
A total of 13 (12%) episodes of tachycardia (>20% in- 2.2, 13.9) – adjustment made for age, sex and ASA stacrease in baseline heart rate) were seen; 7/54(13%) in the tus. Conversely, the use of Ketamine was associated with
Ketamine group and 6/54(11%) in the Fentanyl group, less episodes of hypotension, adjusted odds ratio = 0.18
showing no significant difference in incidence of tachy- (95% confidence interval 0.07, 0.45).
cardia, x2=0.05, p=0.82.
Hypotension was seen from 1 minute of observation
When only considering the means, Ketamine arm had whether measured by systolic, diastolic, or mean blood
higher mean heart rates during follow up compared to pressures in both Ketamine and Fentanyl arm and the
Fentanyl arm despite similar baseline measurement as significantly higher episodes in the Fentanyl arms were
summarised in table 4. These were however not deemed seen from 1 minute and persisted throughout follow up.
clinically significant; largest difference between the two
groups = 5.4 bpm. After adjusting for age, sex and ASA The Survival probability against hypotension was analstatus, use of Ketamine was not significantly associated ysed and it shows faster time to development of hypowith tachycardia during follow up, odds ratio=1.14 (95% tension in the Fentanyl arm during period of follow up,
confidence interval 0.35, 3.67). Linear regression done Logrank test, p<0.001, with more than 75% probability
comparing heart rates (controlling for sex, age and ASA of developing hypotension by 10 minutes in the Fentanyl.
status) showed higher mean heart rates in Ketamine group No rescue interventions were employed within the time
compared to Fentanyl group during the period of follow, of the study and no adverse events were recorded.
Ketamine β-coefficient=2.26(0.66, 3.86), p=0.006. This
was not considered clinically significant: mean heart rates There was no report of any patient with hallucinations
for both groups ranged between 70 and 80bpm in both or confusion deemed to be outside of the realm of post
general anaesthesia emergence behaviour.
groups.
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Table 4: Comparison of heart rate between fentanyl and ketamine groups
Fentanyl group

Ketamine group

Time (min) post-induction
Heart Rate (bpm)
Mean(±SD)
1min
2.5min
5min
7.5min
10min

p value

74.7(10.1)
75.2(10.7)

0.795

75.5(9.9)

0.765

79.8(10.3)

0.02

77.0(9.8)

0.005

74.7(11.3)

0.021

74.9(9.7)
75.2(9.9)
71.6(9.8)
70.1(8.9)

Discussion
As far as our literature review went, this is the first study
investigating the use of the combination of Ketamine
and Propofol versus Fentanyl and Propofol, at the cited doses, to attenuate the haemodynamic response to laryngoscopy and endotracheal intubation. The dosing of
Propofol and Fentanyl forms part of the standard of care
at our hospital. No rescue interventions were employed
within the time of the study and no adverse events were
recorded.
We postulated that at an appropriate (and as yet unknown)
dose, the Ketamine dose would be high enough to confer adequate analgesia needed to reduce the untoward
haemodynamic responses to laryngoscopy and endotracheal intubation and low enough to not manifest its own
cardio-stimulant effects while preventing the commonly
observed drop in blood pressure immediately post-induction (pre-laryngoscopy).

The key finding of this study was that the occurrence
of hypertension (defined as an increase of 20% from
baseline values) post laryngoscopy and endotracheal intubation was not significantly higher, p= 0.06 (statistically or in the author’s opinion, clinically) with the use of
0.5mg/kg Ketamine than with 1.0 μg/kg Fentanyl use.
For instance, there was an episode of increase in SBP
of 100 vs 121mmHg at 7.5 minutes, of MAP from 96 to
118mmHg at 7.5 minutes. On controlling for differences
in age, sex and ASA status, Ketamine still did not show
an association with hypertension. Mean blood pressures
were higher in the Ketamine than the Fentanyl group but
this was not deemed clinically significant, the greatest
difference being a range of 88.6 to 105 mmHg versus a
range of 95.8 to 118.4mmHg in SBP at 2.5 minutes; 66.4
to 82.4mmHg versus 77.5 to 93.6mmHg in MAP at 7.5
minutes; 52.1 to 66.1mmHg versus 58.4 to 76.2mmHg in
DBP at 2.5 minutes for Fentanyl and Ketamine groups
respectively.

In this study, laryngoscopy and endotracheal intubation
were performed 5 minutes after the administration of
the induction medication. This was assumed to allow for
peak effect of these medications to be attained.

On analysis, there was no statistically significant increase
in heart rate from baseline with use of either drug combination, p=0.82. On controlling for differences in age,
sex and ASA status, Ketamine still did not show an as-
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sociation with tachycardia. The study was however not
powered to detect differences in the secondary outcome
measures. The mean heart rates in the Ketamine group
were higher than in the Fentanyl group, but, this was not
deemed clinically significant; the greatest difference in
range of mean heart rate was 61.8 to 81.4 bpm versus
67.2 to 86.8 bpm in the Fentanyl and Ketamine group
respectively at 7.5 minutes post induction.
Post induction hypotension also lends to the risk of myocardial ischaemia and is often seen with opioid based anaesthesia induction. There was a statistically significant
decrease in blood pressure (occurrence of hypotension)
post induction (pre-laryngoscopy) in the Fentanyl group
compared to the Ketamine group, p=<0.001. Again, this
study was not powered to detect differences in this secondary outcome measure. On adjusting for confounders,
Ketamine was still associated with less episodes of post
induction hypotension. The post induction hypotension
observed is likely secondary to peripheral vasodilatory effect of Propofol as well as the direct cardio-depressant
effects of Fentanyl.
It is worth noting that the participants’ preoperative fluid
status was unknown and as such, some of them may have
been relatively fluid depleted. This may have unmasked a
relative intravascular hypovolemia in these patients and
exaggerated the association of either drug with this observation.
After laryngoscopy and endotracheal intubation, Hayakama-Fujii et al demonstrated a significantly greater increase in blood pressure and heart rate above baseline
values in the Propofol-Ketamine group. Patients received
Propofol at 2mg/kg plus either Fentanyl 3.0µg/kg, Ketamine 0.1mg/kg or Fentanyl 3.0µg/kg and Ketamine 0.1
mg/kg18. We postulate that the reason for this difference
from our findings is that the doses are not equianalgesic
(the Ketamine dose is too low to allow for its analgesia
to be effective versus the higher dose of Fentanyl used).
Similar to our study, Singh at al demonstrated statistically significant increases in mean systolic and diastolic
blood pressures at all times until 10 minutes post-induction with a Propofol-Ketamine combination than with
a Propofol-Fentanyl combination4. That study did not
however report analysis of variation of these haemodynamic parameters from baseline. This may not have been
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significant, even if the difference in the means was. Furthermore, it is worth commenting on whether the differences observed are of clinical significance (their study
demonstrated ≤14 mmHg difference in SBP 122.16 versus 132.68 and ≤11mmHg difference in DBP 75.20 versus 86.92 for Fentanyl and Ketamine groups respectively
within a comparable study period time).
Like our study, the same study demonstrated a statistically significant increase in pulse rate post induction with
Propofol-Ketamine than with Propofol-Fentanyl. Again,
this was a difference in mean heart rates rather than from
baseline heart rate. The greatest difference in heart rate
was 14bpm (90 bpm versus 76 bpm in the Ketamine versus Fentanyl groups respectively at 10minutes post induction). They also demonstrated a statistically significant fall
in SBP and DBP with the Fentanyl group in the post-induction pre-laryngoscopy period.
In their study however, Propofol was used at a dose of
1.0mg/kg when combined with Ketamine at a dose of
1.0 mg/kg against Propofol 1.5 mg/kg versus Fentanyl at
2.0 μg /kg. The anaesthetic dose of Ketamine is quoted
as being between 1.0 and 2.0mg/kg and as such it could
be postulated that the relatively high dose of ketamine
allowed for its sympathomimetic effects to manifest. In
addition, the Propofol dose was on the lower range of
anaesthetic dosing (usually 1.0 – 2.0 mg/kg) and may also
have been too low to consistently provide adequate depth
of anaesthesia.
Goyal et al compared the two drugs at similar (but not
equal) dosages for short surgical procedures19. One group
was given Ketamine 0.5 mg/kg and the other Fentanyl
1.5 μg/kg and 2 minutes later given Propofol 2.5 mg/
kg. Laryngeal mask airways were used in this study but
post-induction, pre-intubation haemodynamic variables
were noted. There was significant decrease (P<0.05) in
the systolic and diastolic blood pressure at 1, 3, and 5
minutes in the Fentanyl group whereas the change was
insignificant at 10 minutes. This corresponds with the results of our study. However, it should be noted that at
1 minute, Propofol had not been administered and at 3
minutes the laryngeal mask airway was likely already being inserted. The difference in methodology renders it
difficult to compare those results with the results of this
study.

2761

In a study by Honarmand et al, the largest difference between the Thiopental-Fentanyl and Thiopental-Ketamine
groups in any blood pressure parameter was 6.7mmHg
(109.2 versus 115.09 SBP) and a heart rate difference of
16.2bpm (69.7 versus 85.9), which was statistically significant (17). In that study, Thiopental was used at 4.0 mg/
kg, Fentanyl at 3.0 μg /kg and Ketamine at 0.1 mg/kg.
Again, this represented a difference in means and not a
difference from baseline values. Nevertheless, any difference in variation from baseline that may exists between
the two studies may be attributed to the sub-optimal of
ketamine versus a supra-optimal of Fentanyl which may
have consequently produced lower analgesic effects and
thus less likely to attenuate the pressor response to laryngoscopy and endotracheal intubation.
The observations made in our study may, like our assumption while choosing the Ketamine protocol dose, be
attributed to Ketamine being at a low enough dose that
its sympathomimetic effects are minimal and still high
enough to confer effective analgesia deemed necessary to
attenuate the response to laryngoscopy and endotracheal
intubation. Propofol was used at a dose of 2.0 mg/kg to
increase the likelihood of adequate depth of anaesthesia.
The findings in this study are in keeping with our null
hypothesis: there is no difference in the occurrence of
hypertension post laryngoscopy and endotracheal intubation with the use of Ketamine versus Fentanyl.
According to the study protocol, various rescue actions
and medications were to be employed in the case of
persistent hypertension or tachycardia. This was not observed in any of the groups.
There was no report of any patient with hallucinations or
confusion deemed outside of the realm of post general
anaesthesia behavior. This data was however not acquired
by use of a validated tool. Also, midazolam was sometimes administered within the course of the anaesthetic
(but only after the 10 minutes post induction and before
emergence). As such, it is possible that the 0% occurrence of these neuropsychiatric manifestations may have
been suppressed by benzodiazepine use. Literature does
however show that such adverse effects are minimal to
nil with use of low dose ketamine and with the combined
use with Propofol.

modynamic response to laryngoscopy and endotracheal
intubation, this is the first prospective, double blinded
randomized control trial to employ the study drugs at
these dose combinations using this methodology. It is
thus hoped that these findings will add to the fund of
knowledge concerning maintaining cardiovascular and
haemodynamic stability in the peri-intubation period of
the general anaesthetic.
Limitations
This was not a multi-centre trial. This may affect the generalizability of the results obtained from this study. The
study was powered based on a small number of single
centre studies that had similar sample sizes. It was not
powered to analyse the effect of the study drugs on
tachycardia and post-induction hypotension.
Depth of anaesthesia may have varied as neither the
use of bispectral index (BIS) nor electroencephalogram
(EEG) was employed. As such, the susceptibility to the
adverse haemodynamic responses to laryngoscopy and
endotracheal may have been higher in some patients due
to inadequate depth of anaesthesia.
By general Anaesthesiology protocol, patients are required
to fast for at least 6 hours prior to induction of anaesthesia. Some participants in this study may have fasted for
a longer time. Use of Propofol (known to cause peripheral vasodilatation) could unmask a relative intravascular
hypovolemia. The patients’ preoperative haemodynamic
status was thus unknown and may have contributed to
the occurrence of post induction hypotension.
The logistical and budgetary constraints of this study
would not allow for 12 lead electrocardiography monitoring during the study period. The inclusion of this monitoring would aide in identifying episodes of myocardial ischaemia, which is what the continued search for an
“ideal” induction drug or drug combination attempts to
address.

Conclusion
Based on the results of this study, we conclude that there
is no difference in the occurrence of hypertension and
tachycardia with the use of Ketamine at 0.5 mg/kg in
combination with Propofol at 2.0 mg/kg. In this regard,
Ketamine provides a viable alternative to Fentanyl at 1.0
Strengths
µg/kg for attenuating the pressor response to laryngoscoAfter a thorough literature review, it appears that follow- py and endotracheal intubation. Additionally, our results
ing years of research into methods to attenuate the hae- suggest that Ketamine may protect against post-induction hypotension.
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